Chang H. Kim

Chang H. Kim

Auto-generated profile, based on publicly available information

Chang H. Kim

Division of Cardiology, Department of Medicine Johns Hopkins University School of Medicine Baltimore MD USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
NINino Isakadze
Nino Isakadze
CKChang H. Kim
Chang H. Kim
FMFrancoise A. Marvel
Francoise A. Marvel
JDJie Ding
Jie Ding
ZMZane MacFarlane
Zane MacFarlane
LMLena Mathews
Lena Mathews
Background: Cardiac rehabilitation (CR) is an evidence‐based, guideline‐recommended intervention for patients recovering from a cardiac event, surgery or procedure that improves morbidity, mortality, and functional status. CR is traditionally provided in‐center, which limits access and engagement, most notably among underrepresented racial and ethnic groups due to barriers including cost, scheduling, and transportation access. This study is designed to evaluate the Corrie Hybrid CR, a technology‐based, multicomponent health equity‐focused intervention as an alternative to traditional in‐center CR among patients recovering from a cardiac event, surgery, or procedure compared with usual care alone. Methods: The mTECH‐Rehab (Impact of a Mobile Technology Enabled Corrie CR Program) trial will randomize 200 patients who either have a diagnosis of type 1 myocardial infarction or who undergo coronary artery bypass grafting surgery, percutaneous coronary intervention, heart valve repair, or replacement presenting to 4 hospitals in a large academic health system in Maryland, United States, to the Corrie Hybrid CR program combined with usual care CR (intervention group) or usual care CR alone (control group) in a parallel arm, randomized controlled trial. The Corrie Hybrid CR program leverages 5 components: (1) a patient‐facing mobile application that encourages behavior change, patient empowerment, and engagement with guideline‐directed therapy; (2) Food and Drug Administration‐approved smart devices that collect health metrics; (3) 2 upfront in‐center CR sessions to facilitate personalization, self‐efficacy, and evaluation for the safety of home exercise, followed by a combination of in‐center and home‐based sessions per participant preference; (4) a clinician dashboard to track health data; and (5) weekly virtual coaching sessions delivered over 12 weeks for education, encouragement, and risk factor modification. The primary outcome is the mean difference between the intervention versus control groups in distance walked on the 6‐minute walk test (ie, functional capacity) at 12 weeks post randomization. Key secondary and exploratory outcomes include improvement in a composite cardiovascular health metric, CR engagement, quality of life, health factors (including low‐density lipoprotein‐cholesterol, hemoglobin A1c, weight, diet, smoking cessation, blood pressure), and psychosocial factors. Approval for the study was granted by the local institutional review board. Results of the trial will be published once data collection and analysis have been completed. Conclusions: The Corrie Hybrid CR program has the potential to improve functional status, cardiovascular health, and CR engagement and advance equity in access to cardiac rehabilitation. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05238103.

16 January 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
ABAnjali Bhatla
Anjali Bhatla
CKChang H. Kim
Chang H. Kim
MNMansi Nimbalkar
Mansi Nimbalkar
ANAnthony Sky Ng‐Thow‐Hing
Anthony Sky Ng‐Thow‐Hing
NINino Isakadze
Nino Isakadze
FMFrancoise A. Marvel
Francoise A. Marvel

14 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
CKChang H. Kim
Chang H. Kim
SASadeer Al-Kindi
Sadeer Al-Kindi
YTYasir Tarabichi
Yasir Tarabichi
SGSuril Gohel
Suril Gohel
RVRiddhi Vyas
Riddhi Vyas
SSShankar Srinivasan
Shankar Srinivasan
Background The value of the electrocardiogram (ECG) for predicting long-term cardiovascular outcomes is not well defined. Machine learning methods are well suited for analysis of highly correlated data such as that from the ECG. Methods Using demographic, clinical, and 12-lead ECG data from the Third National Health and Nutrition Examination Survey (NHANES III), machine learning models were trained to predict 10-year cardiovascular mortality in ambulatory U.S. adults. Predictive performance of each model was assessed using area under receiver operating characteristic curve (AUROC), area under precision-recall curve (AUPRC), sensitivity, and specificity. These were compared to the 2013 American College of Cardiology/American Heart Association Pooled Cohort Equations (PCE). Results 7,067 study participants (mean age: 59.2 ± 13.4 years, female: 52.5%, white: 73.9%, black: 23.3%) were included. At 10 years of follow up, 338 (4.8%) had died from cardiac causes. Compared to the PCE (AUROC: 0.668, AUPRC: 0.125, sensitivity: 0.492, specificity: 0.859), machine learning models only required demographic and ECG data to achieve comparable performance: logistic regression (AUROC: 0.754, AUPRC: 0.141, sensitivity: 0.747, specificity: 0.759), neural network (AUROC: 0.764, AUPRC: 0.149, sensitivity: 0.722, specificity: 0.787), and ensemble model (AUROC: 0.695, AUPRC: 0.166, sensitivity: 0.468, specificity: 0.912). Additional clinical data did not improve the predictive performance of machine learning models. In variable importance analysis, important ECG features clustered in inferior and lateral leads. Conclusions Machine learning can be applied to demographic and ECG data to predict 10-year cardiovascular mortality in ambulatory adults, with potentially important implications for primary prevention.

5 September 2022 in European Journal of Preventive Cardiology
Verified
Journal Article
Open access
PDF file
CKChang H Kim
Chang H Kim
FMFrancoise A Marvel
Francoise A Marvel
SMSeth S Martin
Seth S Martin
This editorial refers to ‘Cardioprotective effects of influenza vaccination among patients with established cardiovascular disease or at high cardiovascular risk: a systematic review and meta-analysis’ by V. Jaiswal, et al., https://doi.org/10.1093/eurjpc/zwac152.